Brief: Quince Therapeutics Provides Pipeline Update And Business Outlook For 2023

IRulya Therapeutics

30/01/2023 22:35

Jan 30 (Reuters) - Quince Therapeutics Inc  QNCX.O :
    * QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS
OUTLOOK FOR 2023
    * QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS
OUTLOOK FOR 2023
    * QUINCE THERAPEUTICS - STRONG CASH POSITION OF
APPROXIMATELY $94
MILLION IN CASH, EQUIVALENTS, AND MARKETABLE SECURITIES AS OF
DECEMBER 31, 2022
    * QUINCE THERAPEUTICS -  CASH RUNWAY TO SUPPORT PIPELINE
EXPANSION
THROUGH IN-LICENSING AND ACQUISITION INTO AT LEAST 2028

Source text for Eikon:  ID:nBwdBKzHa 
Further company coverage:  QNCX.O 
 ((Reuters.Briefs@thomsonreuters.com;))